Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

UFS launches journal on name change
2008-11-14

 

At the launch of the journal on name change were, from the left: Prof. Johan Lubbe, research associate of the Unit for Language Management at the UFS and guest editor of the magazine, Dr Lucie Möller, expert on geographical names and place name expert - and also an occasional member of the United Nations' committee of experts, Dr Peter Raper, research associate of the Unit for Language Management at the UFS, and Prof. Theo du Plessis, Director of the Unit for Language Management at the UFS. The magazine is dedicated to Dr Möller.
Photo: Lacea Loader

UFS launches journal on name change

From all the language issues coved in the English and Afrikaans printed media, the name change of place names is receiving the most attention. This is according to Prof. Johan Lubbe, research associate from the University of the Free State’s (UFS) Unit for Language Management, during the recent launch of a journal on name change on the Main Campus in Bloemfontein.

In the journal it is found, among other, that, as a result of the nature of the new democratic foundation of the ANC controlled government which puts the interests of the majority first, there is a move in the thinking and execution of name change. In this way not only names change but art, culture and heritage matters are democratically thought through and planned.

“As a directive from the South African Language Board (Pansalb), the Unit for Language Management at the UFS annually compiles the SA Language Monitor which reports on the language rights situation in South Africa as mainly reported by the print media. Issues about name change appeared throughout and this is why the unit decided to publish a journal with various perspectives on this,” said Prof. Lubbe, who is also the guest editor of the journal.

Other topics discussed in the journal include, among others, language visibility, a historical overview of the change in place names, the Khoisan influence on naming and naming amongst Xhosa speakers.

In a contribution on language visibility it is found that geographical naming policy and the national language policy does not correlate and language visibility as language mechanism is not considered. In a historical overview on the change of place names it is found that name change was never a calculated, political process and only after 2000 mention was made of a conscious, orchestrated process of name change.

In a further contribution on the name change of Johannesburg International airport, it was found that the government, by ignoring the sentiments of the minority, made itself guilty of splitting the nation in spite of pronunciations that nation building is a priority. Where African languages are concerned, it was found that the English name is increasingly being discarded in favour of the Xhosa name. This is apparently connected to the language debate in South Africa.

The journal, “Kritiese perspektiewe op naamsverandering” (“Critical perspectives on name change”) is a supplement to the “Acta Academica”, an accredited national journal that is independently publishing selected research articles in the human sciences and interdissiplinary fields. Nine cooperators from across the country made contributions to the journal.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
14 November 2008
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept